CClinicalTrials.gg
CompletedNCT02271100Updated Mar 3, 2026Results posted

Assessment of the Use of Ultrasound for Epidural Catheter Placement and Comparison With Palpation Technique

An interventional study of ultrasound guidance and palpation guidance in Labor Pain, sponsored by Beth Israel Deaconess Medical Center. Completed at 1 site in United States. Open to female participants aged 18 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-03.

Sponsored by Beth Israel Deaconess Medical Center · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
110
Allocation
Randomized
Ages
18 Years to 64 Years
Sex
Female
01

Study summary

This study is intended to determine whether ultrasound imaging can improve the ability to place a spinal or epidural needle in obstetric anesthesia. By evaluating the use of ultrasound for the placement of epidural catheters the investigators hope to answer two questions:

1. How does the traditional technique based on palpation compare to one using ultrasound to place an epidural catheter? 2. Does ultrasound reduce one potential risk in epidural placement?

Read the detailed description

This study contains two phases:

  1. A prospective, randomized, blinded comparison of ultrasound imaging versus palpation for epidural catheter insertion in laboring women.
  2. A prospective, single cohort, blinded trial to assess whether ultrasound imaging provides a reliable placement below the L3 vertebra.

The initial phase of the investigation will be a randomized comparison of ultrasound versus palpation. Patients will be enrolled in early labor and will be randomized to have their epidural placed with either technique. The technique will be chosen by computer-generated randomization list maintained in opaque sequentially numbered envelopes. Description of the placement technique is below. The primary outcome will be the number of epidural catheters inserted above the intended insertion site. The investigators will also assess the total time required for epidural catheter placement, number of attempts for successful insertion, effectiveness of the epidural catheter for labor pain control.

Following completion of enrollment of the first phase, the second phase of the investigation will enroll patients only into the single-cohort ultrasound arm. The study will use the same methodology as the initial phase, but without randomization due to a single cohort. The primary outcome will be the absolute number of epidural catheters inserted above the L3 vertebral body. The investigators will also assess the effectiveness of the ultrasound markings for guiding placement.

Procedure placement technique After written, informed consent, and standard patient preparation, the epidural catheter will be placed with the patient in the sitting position by a junior resident. In the ultrasound arm, the patient will be first imaged using an appropriate probe, and the identified ultrasound landmarks marked on the skin. The skin will be prepped in the usual fashion, and the needle will be inserted at the identified site and direction determined by ultrasound. In the palpation arm, the skin will be prepped and the needle will be inserted using palpation-identified landmarks to guide the needle. All catheters will be intended to be placed at the L4-L5 interspace as the primary attempt. The L3-L4 interspace will be used as a secondary attempt.

Assessment of final position After insertion of the epidural catheter and administration of the pain relief medication, patients in both groups will be examined by a blinded observer using ultrasound to determine the catheter insertion site and the likely insertion interspace.

If, however, the investigators discover that the use of ultrasound for placement of the epidural catheter may present greater risk than previously anticipated to the pregnant woman or fetus, then the investigators will stop the study after phase 1 and not proceed with phase 2.

02

Conditions studied

  • Labor Pain

Browse trials for

03

In context

Labor Pain

396 studies on the registry are indexed under Labor Pain; 66 are open to participants now.

This study's enrollment of 110 is close to the median of 100 across 326 interventional studies indexed under Labor Pain.

Browse Labor Pain studies →

Lead sponsor

Beth Israel Deaconess Medical Center is the lead sponsor of 560 studies on the registry; 80 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 61 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy ASA I or II parturient
  • Will be receiving neuraxial placement for labor, having been consented for the procedure

Exclusion criteria

Exclusion Criteria:

  • ASA III or IV
  • Unable to participate in the study due to severe pain
  • Contraindications to neuraxial analgesia
  • Previous spinal surgery in the lumbar or sacral area (L1 through Sacrum)
  • BMI greater than 37
  • Height less than 60 inches
  • Significant scoliosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
110 participants (actual)

Study arms

  • Placebo comparator
    palpation guidance

    placement of spinal or combined spinal epidural needle using palpation to guide entry position

    Device: palpation guidance

  • Active comparator
    ultrasound guidance

    placement of spinal or combined spinal epidural using ultrasound to guide entry position

    Device: ultrasound guidance

Interventions

  • Deviceultrasound guidance

    use of ultrasound for entry position estimation

  • Devicepalpation guidance

    use of palpation for position estimation

06

What researchers measure

Primary outcomes

  1. Placement Below L3 Vertebra

    Percentage of participants with catheters placed below the L3 Vertebra

    Time frame: immediately post epidural catheter placement

Secondary outcomes

  1. Time to Placement

    The time in minutes for completion of the procedure measured from the start of the procedure defined as administration of the first medication until the epidural test dose was administered

    Time frame: During the procedure

  2. Success of the Epidural Catheter Placement

    Relief of labor pain defined by verbal pain score less than 4 after administration of medication; verbal pain score consisted of a scale from 0 to 10 with 0 representing no pain and 10 representing worst possible pain, with higher numbers representing greater pain felt by the patient

    Time frame: immediately post epidural catheter placement up to 30 minutes

07

Results

Posted Mar 3, 2026

Participant flow

Participant flow — Overall Study
MilestonePalpation GuidanceUltrasound Guidance
Started5555
Completed5149
Not completed46
Withdrew: Withdrawal by subject22
Withdrew: Physician decision24

Outcome measures

PrimaryPlacement Below L3 Vertebra

Percentage of participants with catheters placed below the L3 Vertebra

Time frame:
immediately post epidural catheter placement
Reported as:
Count of participants · Participants
Placement Below L3 Vertebra
ParticipantsPalpation GuidanceUltrasound Guidance
Placement Below L3 Vertebra4949
SecondaryTime to Placement

The time in minutes for completion of the procedure measured from the start of the procedure defined as administration of the first medication until the epidural test dose was administered

Time frame:
During the procedure
Reported as:
Mean · seconds
Time to Placement
secondsPalpation GuidanceUltrasound Guidance
Time to Placement173 ± 185162 ± 121
SecondarySuccess of the Epidural Catheter Placement

Relief of labor pain defined by verbal pain score less than 4 after administration of medication; verbal pain score consisted of a scale from 0 to 10 with 0 representing no pain and 10 representing worst possible pain, with higher numbers representing greater pain felt by the patient

Time frame:
immediately post epidural catheter placement up to 30 minutes
Reported as:
Count of participants · Participants
Success of the Epidural Catheter Placement
ParticipantsPalpation GuidanceUltrasound Guidance
Success of the Epidural Catheter Placement5149

Adverse events

Collected over 1 hour. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Palpation Guidance0/51 (0%)0/51 (0%)0/51 (0%)
Ultrasound Guidance0/49 (0%)0/49 (0%)0/49 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Palpation GuidanceUltrasound GuidanceTotal
Mean33.7 ± 5.233.3 ± 4.933.5 ± 5.0
Sex: Female, Male
Sex: Female, Male(Participants)Palpation GuidanceUltrasound GuidanceTotal
Female5149100
Male000
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Palpation GuidanceUltrasound GuidanceTotal
Hispanic or Latino8614
Not Hispanic or Latino434386
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Palpation GuidanceUltrasound GuidanceTotal
American Indian or Alaska Native000
Asian7916
Native Hawaiian or Other Pacific Islander000
Black or African American101424
White342660
More than one race000
Unknown or Not Reported000
Nulliparity
Nulliparity(Participants)Palpation GuidanceUltrasound GuidanceTotal
Count of participants292756
08

Study locations

1 site
  • Beth Isreal Deaconess Medical Center
    Boston, Massachusetts 02215, United States
09

References and documents

Study documents

  • Protocol and statistical analysis plan · Dec 8, 2014

Documents are hosted by the registry — open the source record to download them.

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02271100
Lead sponsor
Beth Israel Deaconess Medical Center
Responsible party
Phillip Hess (MD, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
Oct 22, 2014
Start date
Oct 25, 2016
Primary completion
Dec 31, 2018
Completion
Jan 1, 2025
Results posted
Mar 3, 2026
Last update
Mar 3, 2026

Study contacts

Philip E Hess, MD
principal investigator · Beth Israel Deaconess Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion